Document is current
Any future updates will be listed below
-
Authors
Zhang, Kevin Sun
Neelsen, Christian Jan Oliver
Wennmann, Markus
Hielscher, Thomas
Kovacs, Balint
Glemser, Philip Alexander
Görtz, Magdalena
Stenzinger, Albrecht
Maier-Hein, Klaus H.
Huber, Johannes
Schlemmer, Heinz-Peter
Bonekamp, David
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 24 March 2025
Accepted: 1 July 2025
First Online: 13 August 2025
Declarations
:
: MG declares: Payment for lectures: Bayer Vital, AstraZeneca. AS declares: Consulting fee and payment for lectures: Aignostics, Amgen, Astra Zeneca, AGCT, Bayer, Bristol-Myers Squibb, Eli Lilly, Illumina, Incyte, Janssen, MSD, Novartis, Qlucore, Pfizer, Roche, Seagen, Seattle Genetics, Takeda, Thermo Fisher and grants from Bayer, Bristol-Myers Squibb, Chugai, and Incyte. HPS declares: Consulting fee or honorarium: Siemens, Curagita, Profound, Bayer, Bracco. Travel support: Siemens, Curagita, Profound, Bayer, Bracco. Board Member: Curagita. Grants/Grants pending: BMBF, BMWI, EU, Deutsche Krebshilfe. DP declares: Payment for lectures: Profound Medical Inc., Bayer Vital. For the remaining authors none were declared.
